IN2014DN07762A - - Google Patents

Info

Publication number
IN2014DN07762A
IN2014DN07762A IN7762DEN2014A IN2014DN07762A IN 2014DN07762 A IN2014DN07762 A IN 2014DN07762A IN 7762DEN2014 A IN7762DEN2014 A IN 7762DEN2014A IN 2014DN07762 A IN2014DN07762 A IN 2014DN07762A
Authority
IN
India
Prior art keywords
solifenacin
reacting
salt
prepare
organic solvent
Prior art date
Application number
Other languages
English (en)
Inventor
Byoung Suk Lee
Sang Hoon Shin
Ki Young Lee
Original Assignee
Kyung Dong Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyung Dong Pharm Co Ltd filed Critical Kyung Dong Pharm Co Ltd
Publication of IN2014DN07762A publication Critical patent/IN2014DN07762A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/49Cinchonan derivatives, e.g. quinine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/412Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IN7762DEN2014 2012-03-28 2013-03-21 IN2014DN07762A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20120031492A KR101365849B1 (ko) 2012-03-28 2012-03-28 솔리페나신 또는 그의 염의 제조방법 및 이에 사용되는 신규 중간체
PCT/KR2013/002358 WO2013147458A1 (en) 2012-03-28 2013-03-21 Process of preparing solifenacin or salt thereof, and novel intermediate used in the process

Publications (1)

Publication Number Publication Date
IN2014DN07762A true IN2014DN07762A (enrdf_load_stackoverflow) 2015-05-15

Family

ID=49260649

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7762DEN2014 IN2014DN07762A (enrdf_load_stackoverflow) 2012-03-28 2013-03-21

Country Status (9)

Country Link
US (1) US9018379B1 (enrdf_load_stackoverflow)
EP (1) EP2831070A4 (enrdf_load_stackoverflow)
JP (1) JP5891334B2 (enrdf_load_stackoverflow)
KR (1) KR101365849B1 (enrdf_load_stackoverflow)
CN (1) CN104169280A (enrdf_load_stackoverflow)
AU (1) AU2013240842B2 (enrdf_load_stackoverflow)
BR (1) BR112014021223A2 (enrdf_load_stackoverflow)
IN (1) IN2014DN07762A (enrdf_load_stackoverflow)
WO (1) WO2013147458A1 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116986986A (zh) * 2023-07-19 2023-11-03 杭州国瑞生物科技有限公司 一种3-氧代-1-环丁烷羧酸中间体的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2005012I1 (no) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
WO1997035199A1 (en) * 1996-03-20 1997-09-25 The Scripps Research Institute Azatide peptidomimetics
KR100669823B1 (ko) 2001-02-20 2007-01-17 경동제약 주식회사 2-(4-클로로벤조일아미노)-3-[2(1h)-퀴놀리논-4-일]프로피온산의 제조방법 및 그 중간체
AU2003301439A1 (en) * 2002-10-16 2004-05-04 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
GB0312426D0 (en) * 2003-05-30 2003-07-09 Albachem Ltd Purification means
JPWO2005075474A1 (ja) 2004-02-09 2007-10-11 アステラス製薬株式会社 コハク酸ソリフェナシン含有組成物
JPWO2005087231A1 (ja) 2004-03-16 2008-01-24 アステラス製薬株式会社 ソリフェナシン含有組成物
US20080076738A1 (en) * 2004-04-14 2008-03-27 Cai Zhenhong R Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds
JP4803352B2 (ja) * 2005-07-13 2011-10-26 Jsr株式会社 アミノ酸−n−カルボキシ無水物の製造方法
CA2630846A1 (en) * 2005-12-21 2007-07-05 Teva Pharmaceutical Industries Ltd. Intermediates for preparing solifenacin
WO2008062282A2 (en) 2006-11-22 2008-05-29 Medichem S.A. An improved process for the synthesis of solifenacin
AR066206A1 (es) * 2007-03-30 2009-08-05 Medichem Sa Proceso para la sintesis de solifenacina
JP2009538362A (ja) * 2007-07-13 2009-11-05 テバ ファーマシューティカル インダストリーズ リミティド ソリフェナシンの調製方法
CN102989001B (zh) * 2008-04-29 2014-12-03 阿森迪斯药物生长障碍股份有限公司 Peg化的重组人生长激素化合物
WO2010103529A1 (en) * 2009-03-09 2010-09-16 Megafine Pharma(P) Ltd. A new method for the preparation of solifenacin and new intermediate thereof
US8178700B2 (en) * 2009-05-04 2012-05-15 International Business Machines Corporation Method of preparing cyclic carbonates, cyclic carbamates, cyclic ureas, cyclic thiocarbonates, cyclic thiocarbamates, and cyclic dithiocarbonates
WO2011030139A1 (en) * 2009-09-11 2011-03-17 Astrazeneca Ab 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators

Also Published As

Publication number Publication date
JP2015510927A (ja) 2015-04-13
KR101365849B1 (ko) 2014-02-24
JP5891334B2 (ja) 2016-03-22
KR20130109609A (ko) 2013-10-08
WO2013147458A1 (en) 2013-10-03
AU2013240842A1 (en) 2014-08-28
AU2013240842B2 (en) 2015-09-03
EP2831070A4 (en) 2015-08-19
CN104169280A (zh) 2014-11-26
EP2831070A1 (en) 2015-02-04
US20150112072A1 (en) 2015-04-23
US9018379B1 (en) 2015-04-28
BR112014021223A2 (pt) 2020-10-27

Similar Documents

Publication Publication Date Title
EP3778606A3 (en) Condensed imidazolylimidazoles as antiviral compounds
MX2014002087A (es) Formulaciones piretroides.
MX2015003124A (es) Formas polimorficas de enzalutamida y su preparacion.
EP2484673A3 (en) A process for the resolution of (R,S)-nicotine
WO2013112212A3 (en) Metal-organic frameworks with exceptionally large pore aperatures
PH12013501718A1 (en) Production method of optically active dihydrobenzofuran derivative
IN2015KN00323A (enrdf_load_stackoverflow)
DK2548949T3 (da) Mikroorganisme med forbedret produktion af 5'-xanthosinmonophosphat og 5'-guaninmonophosphat samt fremgangsmåde til fremstilling af 5'-xanthosinmonophosphat og 5'-guaninmonophosphat under anvendelse af samme
NZ727045A (en) Camsylate salt of (1r,1’r,4r)- 4-methoxy-5’’-methyl-6’-[5-(prop-1-yn-1-yl)pyridin-3-yl]-3’h-dispiro[cyclohexane-1,2’-indene-1’,2’’-imidazol]-4’’-amine
WO2012178129A3 (en) Quaternary heteroatom containing compounds
MY164371A (en) Method for preparing cysteine or a derivative thereof using a novel o-phosphoserine sulfhydrylase
MX2015011724A (es) Sal de sodio del acido (2s, 5r) -6-benciloxi-7-oxo-1,6-diaza-bicic lo [3.2.1] octano-2-carboxilico y proceso para su preparacion.
MY170511A (en) Colonoscopy-preparation
PH12015500794A1 (en) Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
IN2013MU01431A (enrdf_load_stackoverflow)
MY165744A (en) Process for the preparation of trisilylamine from monochlorosilane and ammonia
IN2014DN07762A (enrdf_load_stackoverflow)
WO2014064712A3 (en) An improved process for the preparation of fulvestrant
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
EA201200756A1 (ru) Лиофилизат соединения бороновой кислоты
MX349985B (es) Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi.
WO2014042605A9 (en) New tiotropium bromide crystalline form
IN2013MU03755A (enrdf_load_stackoverflow)
HK1219949A1 (zh) 決奈達隆及其鹽的製備方法
TR201111589A2 (tr) Tiotropyum bromür susuz kristal formu.